Literature DB >> 11893526

Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans.

Amrita Kamat1, Margaret M Hinshelwood, Barbara A Murry, Carole R Mendelson.   

Abstract

In humans, aromatase P450, which catalyses conversion of C(19)-steroids to estrogens, is expressed in several tissues, including gonads, brain, adipose tissue, skin and placenta, and is encoded by a single-copy gene (CYP19); however, this does not hold true for all species. The human gene is approximately 130 kb and its expression is regulated, in part, by tissue-specific promoters and by alternative splicing mechanisms. Using transgenic mouse technology, it was observed that ovary-, adipose tissue- and placenta-specific expression of human CYP19 is directed by relatively small segments of DNA within 500 bp upstream of each of the tissue-specific first exons. Thus, the use of alternative promoters allows greater versatility in tissue-specific regulation of CYP19 expression. Characterization and identification of transcription factors and crucial cis-acting elements within genomic regions that direct tissue-specific expression will contribute to improved understanding of the regulation of CYP19 expression in the tissues that synthesize estrogens under both physiological and pathophysiological conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893526     DOI: 10.1016/s1043-2760(02)00567-2

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  55 in total

Review 1.  Evolutionary origins of the estrogen signaling system: insights from amphioxus.

Authors:  G V Callard; A M Tarrant; A Novillo; P Yacci; L Ciaccia; S Vajda; G-Y Chuang; D Kozakov; S R Greytak; S Sawyer; C Hoover; K A Cotter
Journal:  J Steroid Biochem Mol Biol       Date:  2011-04-14       Impact factor: 4.292

2.  Estrogen-related receptor gamma (ERRgamma) mediates oxygen-dependent induction of aromatase (CYP19) gene expression during human trophoblast differentiation.

Authors:  Premlata Kumar; Carole R Mendelson
Journal:  Mol Endocrinol       Date:  2011-07-14

Review 3.  Natural products as aromatase inhibitors.

Authors:  Marcy J Balunas; Bin Su; Robert W Brueggemeier; A Douglas Kinghorn
Journal:  Anticancer Agents Med Chem       Date:  2008-08       Impact factor: 2.505

4.  Regulation of adipose oestrogen output by mechanical stress.

Authors:  Sagar Ghosh; Keith Ashcraft; Md Jamiul Jahid; Craig April; Cyrus M Ghajar; Jianhua Ruan; Howard Wang; Megan Foster; Daniel C Hughes; Amelie G Ramirez; Tim Huang; Jian-Bing Fan; Yanfen Hu; Rong Li
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 5.  Steroidogenesis in the skin: implications for local immune functions.

Authors:  Andrzej Slominski; Blazej Zbytek; Georgios Nikolakis; Pulak R Manna; Cezary Skobowiat; Michal Zmijewski; Wei Li; Zorica Janjetovic; Arnold Postlethwaite; Christos C Zouboulis; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2013-02-19       Impact factor: 4.292

6.  Estrogen receptor alpha (ERalpha) mediates stimulatory effects of estrogen on aromatase (CYP19) gene expression in human placenta.

Authors:  Premlata Kumar; Amrita Kamat; Carole R Mendelson
Journal:  Mol Endocrinol       Date:  2009-03-19

7.  Transcriptional control of human antigen R by bone morphogenetic protein.

Authors:  Selvi C Jeyaraj; Mamata Singh; Dina A Ayupova; Suman Govindaraju; Beth S Lee
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

8.  Coding region structural heterogeneity and turnover of transcription start sites contribute to divergence in expression between duplicate genes.

Authors:  Chungoo Park; Kateryna D Makova
Journal:  Genome Biol       Date:  2009-01-28       Impact factor: 13.583

Review 9.  BRCA1, hormone, and tissue-specific tumor suppression.

Authors:  Yanfen Hu
Journal:  Int J Biol Sci       Date:  2008-12-13       Impact factor: 6.580

10.  In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.

Authors:  Anne E Lykkesfeldt; Katrine L Henriksen; Birgitte B Rasmussen; Hironobu Sasano; Dean B Evans; Susanne Møller; Bent Ejlertsen; Henning T Mouridsen
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.